ABVC Biopharma (NASDAQ:ABVC) is a biopharmaceutical company focused on developing and commercializing a diverse range of therapeutic and diagnostic products. It aims to address unmet medical needs in areas such as oncology, central nervous system disorders, and ophthalmology through its innovative research and development strategies. The company's projects range from early-stage discovery to advanced clinical trials, with a commitment to bringing novel treatments and solutions to patients worldwide. ABVC Biopharma pursues partnerships and collaborations to accelerate its product development pipeline and expand its market reach, with the goal of improving patient outcomes and delivering shareholder value.